• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/25

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

25 Cards in this Set

  • Front
  • Back
IBS epidemiology
5-10% population

F>M

more common under 50 yo
IBS definition
abdominal pain
constipation and/or diarrhea
bloating/distention

functional bowel disorder - cant see abnormality on physical findings
IBS dx
abdominal pain at least 3 days per month in last 12 weeks

improvement with defacation, change in stool frequency, change in stool form

onset >6 months prior to diagnosis

types:
IBS constipation predominance
IBS diarrhea predominance
IBS pathophysiology
(1) neuromusuclar dyfunction

(2)abnormal brain-GI tract interactions

(3)immune activations

(4)genetic influence

(5)psychological distress

(6)intestinal flora disturbances
path of IBS

neuromuscular dysfunction
Abnormal colonic motility
Visceral hypersensitivity

Diarrhea – stronger, more frequent muscle contraction
Feces move through colon too quickly
Constipation – less frequent contractions or too strong and block passage

Visceral hypersensitivity – pain out of proportion to motility changes
Discomfort during normal events
Pain in areas other than bowels – more diffuse
path of IBS

abnormal brain GI tract interactions
Signals from enteric nervous system inside digestive tract

Neuronal control – enteric and sympathetic/parasympathetic

Serotonin – potential target for mediator
Released by mucosal ECL cells with pain stimulus
Activates peristalsis – increased/decreased transit
Activates pathways that mediate pain
path of IBS

immune activations
Salmonella, shigella, campylobacter, e.coli, c. jejuni proceed IBS

T cell activation in IBS
Particular T cell mediated
path of IBS

genetic influence
Increased frequency in adults with afflicted family member
Twin studies
path of IBS

psychological distress
Exacerbates GI symptoms
Affects illness experience and behavior
path of BIS

intestinal flora disturbances
Colon normal has large amount of bacteria
When bacteria grows into small intestine, can have symptoms similar to IBS
Bloating, diarrhea, gas, pain, etc.

Challenges to theory – lot of patients are on PPIs
Must studies include patients on PPIs which are known to increase bacterial overgrowth
Tx of IBS (non medical)
Treat according to predominant symptom
Mild: Eliminate food/drink and medications that make symptoms worse
Moderate: symptom diary
Keep track of foods, drinks, stressors
Keep track of timing of symptoms

Behavioral tx
Relaxation therapy
Hypnosis
Biofeedback
CBT
Medications for IBS stool
diarrhea - bulking agents

constipation - laxatives
lubiprostone

antidiarrheals
operamide
diphenoxylate with atropine

severe IBS - antidepressants to reduce pain
Lubiprostone
approved for chronic functional constipation in IBS

increases intestinal fluid secretion by stimulating CL channel

does not change electrolyte concentrations in serum
operamide
Antidiarrheal

slows transit time through colon

increasing resorption of intestinal water
diphenoxylate with atropine
antidiarrheal

reduces transit time, reduces intestinal muscle spams

anticholinergic activity
Tx of pain and bloating
antispasmodics for pain
inhibit smooth muscle contraction
(1)alosetron
(2) tegaserod maleate

antidepressants
reduce pain threshold
(1)tricyclic
(2)SSRI - improved quality of life, symptom frequency, and abdominal pain
Alosetron
5TH3 antagonist

reduces viscreal pain and slows colonic transit

approved for women

can cause ischemic colitis and constipation
tegaseord maleate
5HT4 agonist

stimulate intestinal motility via cholinergic transmission

augment peristaltic reflex

enhances secretion, reduces visceral hypersensitivity
tricyclics in IBS
reduce pain threshold

alter GI transit
SSRIs in IBS
improved quality of life, symptom frequency, and abdominal pain
antibiotics and IBS
for small bowel overgrowth
rifaxamin, metronidzaole, quinolones

dx with hydrogen breath test
rifaxamin
for small bowel overgrowth
metronidazole
for small bowel overgrowth
quinolones
for small bowel overgrowth
probiotics for IBS
bifidobacterium infantisi improved pain/discomfort, bloating/distention bowel difficulty

no other probiotic improves IBS symptoms